Policy & Regulation

Executive Orders No. 13985 (2021) and 14091 (2023) require federal agencies to ensure that their policies and services, including data collection, advance equitable outcomes for all populations. The Assistant Secretary for Planning and Evaluation (ASPE) and the U.S.

The Inflation Reduction Act (IRA) is helping people with Medicare, including nearly 30 million women enrolled in Part D. Our review shows that, in 2020, about 733,000 women enrolled in Part D and B would have benefited from the IRA’s $35 insulin cap and, in 2021, about 2 million women would not have had any out-of-pocket costs for recommended adult vaccines covered by Part D.

This issue brief presents estimates of children’s average monthly gains in Medicaid and CHIP eligibility under a federal 12-month CE requirement. Characteristics and household income of children gaining eligibility under a national, 12-month CE policy are also presented.

This issue brief presents Marketplace enrollment and plan selections by race and ethnicity among 2015-2023 Open Enrollment Period enrollees in HealthCare.gov states using combined self-reported race and ethnicity information with imputed data for missing values.

The Affordable Care Act substantially transformed the market for non-group private health insurance, introducing new consumer protections and coverage standards and establishing Health Insurance Marketplaces.

This Issue Brief focuses on the changes over time in Marketplace insurance coverage in HealthCare.gov states and the association between various demographic and plan characteristics including income, metal level selection, race and ethnicity, and premiums by leveraging self-reported and imputed data.

The FY 2025 HHS Evaluation Plan details the Department of Health and Human Services’ (HHS) efforts to answer the priority questions presented in the current HHS Evidence Building Plan. This plan provides both an overview of HHS evaluation activities planned for FY 2025 and detailed information for each new and continuing evaluation effort.

In 2022, 43.3 million Medicare Part D enrollees (82 percent) filled 1.1 billion prescriptions for generic prescription drugs. While most enrollees filled at least one prescription for $2 or less, most (54 percent) paid more than $2 for at least one generic drug. Over 6 million enrollees filled at least one prescription for over $20.

According to the most recent National Health Interview Survey data, the national uninsured rate in the third quarter of 2023 was 7.7 percent, unchanged statistically from the first two quarters of 2023.